FTI Consulting Survey Shows Life Sciences Leaders' Outlook Tempered by Concerns Around Fundraising, Policy Shifts and Cybersecurity Heading into 2026

Industry Leaders Point to Challenging Political and Economic Environment Key Legislation Expected to Impact Supply Chain and Drug Costs Recent M&A Momentum Offset by Challenging Fundraising Environment Artificial Intelligence (AI) Seen as Key Investment Area WASHINGTON, Dec. 16, 2025 (GLOBE NEWSWIRE) -- FTI Consulting, Inc. (NYSE: FCN) today announced findings from its fifth annual U.S. Healthcare & Life Sciences Industry Outlook 2026, which revealed that leaders are less optimistic about the state of the i ...